Market Capitalization (Millions $) |
71 |
Shares
Outstanding (Millions) |
18 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-10 |
Cash Flow (TTM) (Millions $) |
-8 |
Capital Exp. (TTM) (Millions $) |
0 |
Genenta Science S P A
Genenta Science S.p.A. is a biotechnology company based in Milan, Italy. The company specializes in developing innovative gene therapies to treat various types of cancer. Genenta Science focuses on using a unique approach called Immune Reprogramming Gene Therapy (IRGT) to modify the patient's immune cells for targeted cancer treatment. IRGT involves modifying hematopoietic stem cells and reprogramming them to express specific genes that activate the immune system against cancer cells. This approach aims to enhance the body's ability to fight cancer and potentially offer new treatment options for patients. Genenta Science is dedicated to advancing the field of gene therapy and improving the lives of cancer patients.
Company Address: Via Olgettina No. 58 Milan 20132
Company Phone Number: 02-2643-4681 Stock Exchange / Ticker: NASDAQ GNTA
GNTA is expected to report next financial results on April 20, 2024. |
|
|